baby tech company owl and telehealth staffing and services companies. Wheel Announced a partnership to enable Wheel clinicians to prescribe Owlet medical pulse oximetry infant wire-free socks to caregivers.
Owlet's BabySat received FDA approval Last year, pulse oximetry technology was used to monitor babies' heart rates and oxygen saturation levels, alerting caregivers if readings fell outside of prescribed ranges.
The company says the device is used as recommended by a healthcare provider when an infant needs to be monitored at home.
The partnership will allow caregivers of infants to obtain BabySat prescriptions directly through Wheel's online portal or their physician.
After receiving a prescription, caregivers can use Wheel's BabySat telemedicine platform to order socks at little or no cost. The platform integrates with durable medical equipment suppliers who can bill insurance companies for their products on behalf of caregivers.
„We are excited to announce our strategic partnership with Owlet, the leader in smart infant monitoring,“ said Michelle, CEO of Wheel. „This partnership will expand healthcare access and care for all Americans, especially growing families. „This is an important milestone in our mission to simplify delivery.“ Davey said in a statement.
bigger trends
Listed Owlet is Warning letter from FDA That caused the stock price to plummet. The agency said Owlet markets its products as „diagnostic“ tools, which require 510(k) clearance.
One year later, the company dream socks plus, a consumer sleep wearable that can be worn around the feet by children up to age 5 or weighing up to 55 pounds. Designed to provide insight into children's sleep.
Owlet has since attracted significant investment. Going public through a SPAC In 2021.
In 2023, the company will $30 million In private financing. In February of this year, it raised another $9 million.
The company reported fiscal 2023 sales of $54 million and a net loss of approximately $32.9 million. This was a 59% decrease from $79.3 million in 2022. Adjusted EBITDA loss for the year was approximately $16.3 million, a 76% decrease from $68.3 million in fiscal 2022. 2022.
On the other hand, Wheel Co., a privately held company, $150 million in Series C funding In 2022, the total amount raised will be $216 million.
In 2020, the company Released for $13.9 million And a year later, it was secured $50 million in Series B funding round.
In 2022, got the wheels GoodRx's back-end virtual care technology includes: Good R Care's EHR, clinical management tools, patient experience software, $19.5 million in cash;
Last year, the telehealth staffing and services company recognized that. Reduce workforce by 28% and lay off 56 employees. This layoff marks the second round of layoffs at the startup. lay off 17% of staff during the summer.
Wheels in March announced a partnership Partnering with Mark Cuban Cost Plus Drug Company, mental health platform Talkspace, and diagnostic services company Health Gorilla.
Through this partnership, Wheel will provide mental health services, affordable home-delivered prescription drug pricing, testing and diagnostics through an integrated virtual care ecosystem.